Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A new treatment using conjugated linoleic acid in nanovesicles can rejuvenate hair follicles and improve hair growth in androgenic alopecia.

The prototype for analyzing skin aging works technically and clinically.

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

RCS-01 therapy is safe and may improve skin structure by affecting gene expression.

Taking high doses of Cyproterone acetate significantly increases the risk of meningioma in females.

Baricitinib significantly regrows hair in teens with severe alopecia areata.

New pregnane derivatives were more effective than finasteride at inhibiting a key enzyme for male pattern baldness.

The PW91 method is best for calculating the basic physical and chemical properties of Finasteride, a drug used for prostate issues and hair loss.

Tiny lipid particles carrying 17-α-estradiol gather in hair follicles, which may help target alopecia treatment.

Researchers found a new gene area linked to male-pattern baldness, which, along with another gene, significantly increases the risk of hair loss in men.

A new method accurately measures nine specific hormones in human blood.

Only one of the two K16 genes on chromosome 17 makes a functional protein for keratin filaments.

The combination therapy improved severe alopecia areata in a patient after 14 days.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

Simple methods using DHT levels effectively assess compliance.

Most children with a common hemochromatosis genotype had elevated iron levels but no severe symptoms.

A 7-year-old girl developed early pubic hair growth without other puberty signs, diagnosed as isolated premature pubarche.

An 8-year-old boy with Recklinghausen's Disease shows various symptoms and is from a family with close genetic ties.

The trial aims to test a new treatment for hair loss in young men using stem cell-derived vesicles.

PEA boosts allopregnanolone production and reduces oxidative stress in brain cells.

3α, 17β-androstanediol-glucuronide is not a useful marker for androgen excess but may help monitor certain treatments.

A 21-year-old male with a rare genetic disorder experienced sudden hair loss and high DHEAS levels, likely due to a condition similar to PCOS, usually seen in women.

Male genital development is driven by androgen signaling and understanding it could help address congenital anomalies.

Finasteride may cause breast enlargement in some men.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

The discovery of 5α-reductase deficiency in guevedoces led to the development of important urologic medications.

Hair steroid profiling is a feasible, non-invasive alternative to serum analysis for assessing hormone levels and metabolism.

Finasteride may help reduce prostate cancer risk.